(IN BRIEF) Bayer has highlighted an important development in cardiovascular health assessment following the Saudi Heart Association’s recent publication recommending greater focus on the early detection of subclinical atherosclerosis in clinical practice. The research supports a more personalized approach to … Read the full press release
Posted in Business, Government, Healthcare, Pharma & Biotech, Science, Society, Switzerland, Technology
Tagged ABI, ankle-brachial index, Atherosclerosis, Bayer, Bayer Advances Cardiovascular Health Assessment Through Focus on Subclinical Atherosclerosis Screening, Bayer and Saudi Heart Association Collaboration Strengthens Focus on Preventive Cardiovascular Care, Bayer Consumer Health, Bayer Supports Early Cardiovascular Risk Detection Following New Saudi Heart Association Recommendations, CAC scoring, cardiac care, cardiovascular disease, cardiovascular health, cardiovascular risk assessment, carotid ultrasound, CCTA, Clinical Practice, Consumer Health division, coronary artery calcium scoring, coronary computed tomography angiography, CVD, Dr. Ricardo Salazar, Early Detection, family history, Gasser Yousry, genetic predisposition, healthcare professionals, heart attack, high cholesterol, hypertension, modifiable risk factors, Non-invasive Imaging, non-modifiable risk factors, patient outcomes, personalized cardiovascular care, physical inactivity, policymakers, poor diet, Prevention Strategies, primary prevention, Prof. Dr. Waleed Al Habeeb, researchers, risk re-stratification, risk stratification, Saudi Arabia, Saudi Heart Association, Saudi Heart Association Research Aligns with Bayer’s Personalized Approach to Cardiovascular Risk Prevention, secondary prevention, SHA, smoking, stroke, subclinical atherosclerosis, Vision 2030
(IN BRIEF) Bayer has expanded its partnership with the International Organization for Migration to deliver more than 225 metric tonnes of vegetable and corn seeds in 2026 to vulnerable communities worldwide. The initiative supports Bayer’s Zero Hunger Pledge and focuses … Read the full press release
Posted in Agriculture, Business, Environment, Financial, Food & Beverage, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Switzerland, Technology, Ukraine
Tagged agriculture support, Bayer, Bayer advances zero hunger commitment with seed distribution initiatives across Africa and Ukraine, Bayer and IOM expand global partnership to strengthen food security through large-scale seed donations, climate resilience, corn seeds, displaced communities, food security, humanitarian aid, International Organization for Migration, IOM, Kenya, Nigeria, nutrition security, seed donation, UKRAINE, vegetable seeds, Zambia, zero hunger pledge
(IN BRIEF) Evotec SE announced that Bayer has initiated a Phase 2 clinical study for BAY 3401016, a Semaphorin-3A-targeting monoclonal antibody being developed as a potential therapeutic option for patients with Alport syndrome. As part of the companies’ kidney disease … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, Science, Technology
Tagged Alport syndrome, ASSESS study, BAY 3401016, Bayer, clinical development, COL4A3, COL4A4, COL4A5, end stage renal disease, Evotec, Evotec Announces Phase 2 Advancement of BAY 3401016 for Alport Syndrome in Collaboration with Bayer, milestone payment, monoclonal antibody, phase 2 trial, podocytes, rare kidney disease, Sema3A, Semaphorin-3A
(IN BRIEF) A new expert-led publication in the European Medical Journal, supported by Bayer, highlights the growing global burden of allergic rhinitis (hay fever) among children. Affecting 20% of children worldwide, the condition is linked to reduced academic performance, poor … Read the full press release
Posted in Education, Environment, Infrastructure & Utilities, News, Pharma & Biotech, Science, Society, Switzerland, Technology
Tagged academic performance, allergic rhinitis, allergy-friendly schools, antihistamines, ARIA guidelines, asthma prevention, Basel, Bayer, child wellbeing, children’s health, climate change, European Medical Journal, Experts Call for Urgent Action to Address the Growing Impact of Allergic Rhinitis on Children’s Health and Education, Experts Urge Global Action to Combat the Hidden Toll of Allergic Rhinitis on Children’s Education and Wellbeing, Gabriela Zuniga, global health, hay fever, indoor allergens, Lei Cheng, Mário Morais-Almeida, Michael Blaiss, non-sedating antihistamines, pediatric allergy, pollution, Ricardo Salazar, school environment, sleep disturbance, urbanization
(IN BRIEF) Bayer has officially opened a modern laboratory in Darmstadt, Germany, designed to accelerate research and development in phytomedicines and biotics, with a particular focus on Iberogast and future plant-based health innovations. The facility will enable rapid prototyping, foster … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Aude Barroso, Bayer, Bayer expands Darmstadt site with new laboratory for phytomedicine and biotics innovation, biotics, Chloe Picot, consumer healthcare innovation, Darmstadt, gastrointestinal health, Germany, herbal remedies, Iberogast®, natural health solutions, New Bayer laboratory in Darmstadt accelerates development of plant-based consumer health products, partnership, phytomedicines, plant-based health, research and development, sustainability, Thorsten Umland
(IN BRIEF) Selex Gruppo Commerciale has signed a renewable energy purchase agreement with Iberdrola for 1,250 GWh of photovoltaic power, equal to 125 GWh annually from plants with 77 MW of capacity starting in July 2026. The PPA features a … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Industrial, Infrastructure & Utilities, Italy, News, Spain, Technology
Tagged 000 tons of CO₂ emissions annually, 250 GWh of photovoltaic energy under innovative framework agreement for group companies, A&O, Acciaierie Venete, Amazon, Bayer, BTicino, C+C, CO₂ reduction, decarbonization, Famila, Iberdrola, Iberdrola partners with Selex to deliver 1, Italy energy transition, Mercedes-Benz, Meta, Microsoft, Pexapark Renewables Market Outlook 2025, photovoltaic energy, Power Purchase Agreement, PPA, renewable energy, retail distribution, Salzgitter, Selex accelerates sustainability with Iberdrola renewable PPA cutting 37, Selex Gruppo Commerciale, sustainability, vodafone
(IN BRIEF) Bayer has filed for EU approval of icafolin‑methyl, its first new herbicide mode of action in over 30 years, after earlier submissions in Brazil, the U.S., and Canada. With peak sales estimated at €750 million, icafolin‑methyl is slated for … Read the full press release
Posted in Agriculture, Business, Chemicals, Environment, Financial, Germany, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged artificial intelligence, Bayer, Brazil launch, CropKey, DSO operating model, EU registration, glyphosate, icafolin‑methyl, Mike Graham, novel mode of action, no‑till, peak sales €750 million, post‑emergent weed control, Rachel Rama, reduced tillage, reduced‑risk herbicide, Regenerative Agriculture, sustainability, sustainable farming, weed resistance
(IN BRIEF) Bayer and M2i Group have extended their distribution partnership to cover Asia-Pacific, Latin America, and the United States, following a successful 2023 agreement in Europe and Africa. This exclusive deal will enable Bayer to market M2i’s pheromone gel … Read the full press release
Posted in Agriculture, Business, Environment, Financial, France, Germany, Government, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Asia-Pacific, Bayer, biological crop protection, complex molecules, digital crop-management, exclusive distribution, Latin America, M2i Group, partnership, pest monitoring, pheromone gels, Phillippe Guerret, Press technology, Ralf Glaubitz, sustainability, sustainable agriculture, United States, VYNYTY Press series
(IN BRIEF) Bayer has opened a new maize seed facility in Kabwe, Zambia, with a 32-million-euro investment that triples its current production capacity. The facility, part of Bayer’s growth strategy in Africa, is expected to provide high-yielding maize seeds to … Read the full press release
Posted in Agriculture, Business, Germany, Healthcare
Tagged 10 million, 30 million people, 32-million-euro investment, 6.4 million, agronomic training, Bayer, Bill Anderson, community development, Crop Science Division, food security, Hakainde Hichilema, health center, high-yielding seeds, job creation, Kabwe, maize seed facility, smallholder farmers, sub-Saharan Africa, sustainable growth, water infrastructure, Zambia
(IN BRIEF) A collaborative study led by Bayer and Hurdle, in partnership with top academic institutions including the University of Birmingham and the University of Edinburgh, has introduced and validated InflammAge—a novel, non-invasive saliva-based biomarker that quantifies systemic chronic inflammation, … Read the full press release
Posted in Business, Education, European Union, Financial, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged aging, Bayer, Cancer, cardiovascular disease, chronic inflammation, CRP, Dr. Daniel Martin-Herranz, Generation Scotland, Hurdle, InflammAge, lifestyle factors, neurodegenerative disorders, non-invasive testing, partnership, precision medicine, Professor Janet M Lord, Professor Riccardo E. Marioni, remote health monitoring, saliva-based DNA methylation biomarker, University of Birmingham, University of Edinburgh, Veronika Óvári
(IN BRIEF) Recent studies suggest that current cardiovascular risk assessment methods may be inadequate and call for a more personalized approach. Tools like carotid ultrasound offer promising solutions for more precise evaluations, enabling targeted interventions such as aspirin therapy, which … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged aspirin therapy, Bayer, cardiovascular disease, cardiovascular health, Cardiovascular risk, carotid ultrasound, coronary artery calcium scoring, Dr. Michael Blaha, Dr. Ricardo Salazar, healthcare access, heart disease prevention, ischemic events, medical research, personalized medicine, risk assessment, stroke prevention, subclinical atherosclerosis, subclinical plaque
(IN BRIEF) Bayer and Evotec have updated their strategic collaboration to focus on developing precision treatments for cardiovascular diseases (CVDs). Leveraging Evotec’s expertise in disease modelling using human induced pluripotent stem cells (iPSCs), the collaboration aims to identify and validate … Read the full press release
Posted in Business, Education, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Bayer, Cardiovascular Therapies, Dr Cord Dohrmann, Dr. Christian Rommel, Evotec, Juergen Eckhardt, partnership, sustainability
(IN BRIEF) Bayer has invested $250 million in a new cell therapy production plant in Berkeley, California, USA. This investment aims to support the production of materials for clinical trials and potential commercial launches of BlueRock Therapeutics’ bemdaneprocel (BRT-DA01), an … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science
Tagged Bayer, Bemdaneprocel, Berkeley, BRT-DA01, California, Cell Therapy Plant, Holger Weintritt, Parkinson's disease, partnership, Seth Ettenberg, Stefan Oelrich, sustainability, USA
(IN BRIEF) Bayer is making a significant investment of EUR 220 million in research and development (R&D) at its Monheim site in Germany, focusing on its Crop Protection business. This represents the company’s largest single investment in Crop Protection in … Read the full press release
Posted in Agriculture, Business, Education, Environment, Financial, Germany, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Bayer, crop protection, Dr. Axel Trautwein, Dr. Robert Reiter, INNOVATION, investment, Rachel Rama, Regenerative Agriculture, sustainability
(IN BRIEF) Pairwise and Bayer have entered into a new five-year, multi-million Dollar collaboration focusing on gene-edited short-stature corn. Building on their initial partnership for corn, soy, wheat, cotton, and canola, this collaboration aims to optimize and enhance gene-edited short-stature … Read the full press release
Posted in Agriculture, Business, Environment, Germany, Industrial, Management, News, Pharma & Biotech
Tagged Bayer, Bob Reiter, Gene-Edited Short-Stature Corn, Pairwise, partnership, Smart Agriculture, sustainability, Tom Adams
(IN BRIEF) BlueRock Therapeutics and bit.bio have announced a collaboration and option agreement to discover and manufacture iPSC-derived regulatory T cells (Tregs) for therapeutic use. Tregs are crucial for immune system balance and controlling excessive immune reactions, making them potential … Read the full press release
Posted in Business, Education, Germany, Healthcare, Management, News, Pharma & Biotech, Science
Tagged Autoimmune Disorders, Bayer, bit.bio, bit.bio’s opti-ox™, BlueRock Therapeutics, iPSC, Mark Kotter, partnership, Stefan Irion, T Cell Therapies, Tregs
(IN BRIEF) Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company owned by Bayer AG, has begun the Phase 1/Phase 2 LION-CS101 clinical trial for patients with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). The trial is evaluating AB-1003 (LION-101), an investigational … Read the full press release
Not intended for U.S. and UK Media (IN BRIEF) Bayer AG has partnered with Acuitas Therapeutics, Inc. to enhance its gene therapy portfolio. Acuitas’ lipid nanoparticle (LNP) delivery technology will enable targeted and efficient delivery of gene editing RNA components … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech
Tagged Acuitas Therapeutics, AskBio, Asklepios BioPharmaceutical, Bayer, Clinically validated, components, DNA, Dr. Thomas Madden, Friedemann Janus, gene editing, gene therapy, High potency ionizable lipid technology, Jost Reinhardt, lipid nanoparticle, LNP, LNP carriers, messenger RNA, molecular therapeutics, mRNA, RNA, vivo gene editing
Not intended UK Media (IN BRIEF) Bayer and Cedilla Therapeutics have entered into an exclusive license agreement to develop and commercialize Cedilla’s CyclinE1/CDK2 complex inhibitors for precision oncology. These inhibitors target oncogenic drivers and offer a unique method of action, … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech
Tagged Bayer, CDK2, CDK2 inhibitors, Cedilla, Cedilla Therapeutics, Cyclin Dependent Kinase 2, cyclin E, CyclinE1, CyclinE1/CDK2 complex inhibitors, Dominik Ruettinger, Exclusive license agreement, M.D., Neil Exter, oncogenic drivers, Ph.D., precision oncology
(IN BRIEF) Bayer has announced the recipients of its 2023 Grants4Ag program, which will provide funding and mentorship to researchers working on sustainability and biotechnology in agriculture. The program will award grants ranging from €5,000 to €15,000 and connect researchers … Read the full press release
Posted in Agriculture, Awards, Business, Germany, Management, News, Pharma & Biotech, Science, Technology
Tagged agriculture, Awards, Bayer, biotechnology, Dr. Phil Taylor, grants, Grants4Ag program, innovative, mentorship, Prof. Ji Zhou, researchers, sustainability
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?